191 related articles for article (PubMed ID: 6090339)
1. Molecular size variation of EBNA is determined by the EB viral genome.
Gergely L; Sternås L; Dillner J; Klein G
Intervirology; 1984; 22(2):85-96. PubMed ID: 6090339
[TBL] [Abstract][Full Text] [Related]
2. Host cell-dependent regulation of growth transformation-associated Epstein-Barr virus antigens in somatic cell hybrids.
Contreras-Salazar B; Klein G; Masucci MG
J Virol; 1989 Jun; 63(6):2768-72. PubMed ID: 2542588
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a second Epstein-Barr virus-determined nuclear antigen associated with the BamHI WYH region of EBV DNA.
Dillner J; Kallin B; Ehlin-Henriksson B; Timar L; Klein G
Int J Cancer; 1985 Mar; 35(3):359-66. PubMed ID: 2982749
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell lines.
Finke J; Rowe M; Kallin B; Ernberg I; Rosén A; Dillner J; Klein G
J Virol; 1987 Dec; 61(12):3870-8. PubMed ID: 2824821
[TBL] [Abstract][Full Text] [Related]
5. An Epstein-Barr virus (EBV)-determined nuclear antigen (EBNA5) partly encoded by the transformation-associated Bam WYH region of EBV DNA: preferential expression in lymphoblastoid cell lines.
Dillner J; Kallin B; Alexander H; Ernberg I; Uno M; Ono Y; Klein G; Lerner RA
Proc Natl Acad Sci U S A; 1986 Sep; 83(17):6641-5. PubMed ID: 3018741
[TBL] [Abstract][Full Text] [Related]
6. B cell phenotype-dependent expression of the Epstein-Barr virus nuclear antigens EBNA-2 to EBNA-6: studies with somatic cell hybrids.
Contreras-Brodin BA; Anvret M; Imreh S; Altiok E; Klein G; Masucci MG
J Gen Virol; 1991 Dec; 72 ( Pt 12)():3025-33. PubMed ID: 1662694
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of integrated Epstein-Barr virus nuclear antigen 1 and 2 genes in a Burkitt lymphoma cell line after somatic cell fusion with autologous EBV-immortalized lymphoblastoid cells.
Wolf J; Pawlita M; Klevenz B; Frech B; Freese UK; Müller-Lantzsch N; Diehl V; zur Hausen H
Int J Cancer; 1993 Feb; 53(4):621-7. PubMed ID: 8382194
[TBL] [Abstract][Full Text] [Related]
8. Induction of an activated b lymphocyte-associated surface moiety defined by the B2 monoclonal antibody by ebv conversion of an EBV-negative lymphoma line (Ramos): differential effect of transforming (B95-8) and nontransforming (P3HR-1) EBV substrains.
Klein G; Ehlin-Henriksson B; Schlossman SF
J Immunol; 1983 Apr; 130(4):1985-9. PubMed ID: 6300235
[TBL] [Abstract][Full Text] [Related]
9. Primary EBV infection of human umbilical cord lymphocytes and EBV genome-negative lymphoblastoid cell lines (BJAB and Ramos).
Takimoto T; Sato H; Ogura H
Auris Nasus Larynx; 1986; 13(3):199-205. PubMed ID: 3036055
[TBL] [Abstract][Full Text] [Related]
10. Influence of Burkitt's lymphoma and primary B cells on latent gene expression by the nonimmortalizing P3J-HR-1 strain of Epstein-Barr virus.
Rooney C; Howe JG; Speck SH; Miller G
J Virol; 1989 Apr; 63(4):1531-9. PubMed ID: 2538644
[TBL] [Abstract][Full Text] [Related]
11. Establishment of EBNA-expressing cell lines by infection of Epstein-Barr virus (EBV)-genome-negative human lymphoma cells with different EBV strains.
Fresen KO; Hausen H
Int J Cancer; 1976 Feb; 17(2):161-6. PubMed ID: 175026
[TBL] [Abstract][Full Text] [Related]
12. The level of c-fgr RNA is increased by EBNA-2, an Epstein-Barr virus gene required for B-cell immortalization.
Knutson JC
J Virol; 1990 Jun; 64(6):2530-6. PubMed ID: 2159528
[TBL] [Abstract][Full Text] [Related]
13. Analysis of viral gene expression and genome persistence in CD23-positive and -negative subpopulations of Epstein-Barr-virus-infected BL2 cells.
Doyle MG; Crawford DH
Intervirology; 1994; 37(5):236-44. PubMed ID: 7698878
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus nuclear antigen (EBNA): size polymorphism of EBNA 1.
Allday MJ; MacGillivray AJ
J Gen Virol; 1985 Jul; 66 ( Pt 7)():1595-600. PubMed ID: 2991431
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of Epstein-Barr virus derived from P3HR-1 cells.
zur Hausen H; Fresen KO
IARC Sci Publ (1971); 1978; (20):391-6. PubMed ID: 215522
[TBL] [Abstract][Full Text] [Related]
16. An EBV-genome-negative cell line established from an American Burkitt lymphoma; receptor characteristics. EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection.
Klein G; Giovanella B; Westman A; Stehlin JS; Mumford D
Intervirology; 1975; 5(6):319-34. PubMed ID: 181343
[TBL] [Abstract][Full Text] [Related]
17. Hybridization of a myeloid leukemia-derived human cell line (K562) with a human Burkitt's lymphoma line (P3HR-1).
Klein G; Zeuthen J; Eriksson I; Terasaki P; Bernoco M; Rosén A; Masucci G; Povey S; Ber R
J Natl Cancer Inst; 1980 Apr; 64(4):725-38. PubMed ID: 6245297
[TBL] [Abstract][Full Text] [Related]
18. Hybridization between a human epithelial line, infectable by Epstein-Barr virus, and Burkitt lymphoma lines: membrane properties, superinfectability, inducibility and tumorigenicity.
Mitrani-Rosenbaum S; Ber R; Goldblum N; Povey S; Gamliel H; Ben-Bassat H
Int J Cancer; 1982 Nov; 30(5):593-600. PubMed ID: 6295967
[TBL] [Abstract][Full Text] [Related]
19. Somatic cell hybrids between human lymphoma cell lines. V. IdUrd inducibility and P3HR-1 superinfectability of Daudi/HeLa (DAD) and Daudi/P3HR-1 (DIP-1) cell lines.
Moar MH; Ber R; Klein G; Westman A; Eriksson I
Int J Cancer; 1978 Dec; 22(6):669-74. PubMed ID: 82545
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1.
Wang F; Tsang SF; Kurilla MG; Cohen JI; Kieff E
J Virol; 1990 Jul; 64(7):3407-16. PubMed ID: 2352328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
